| __timestamp | ACADIA Pharmaceuticals Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 5078000000 |
| Thursday, January 1, 2015 | 90804000 | 4717000000 |
| Friday, January 1, 2016 | 186456000 | 5096000000 |
| Sunday, January 1, 2017 | 255062000 | 4986000000 |
| Monday, January 1, 2018 | 265758000 | 4214000000 |
| Tuesday, January 1, 2019 | 325638000 | 3806000000 |
| Wednesday, January 1, 2020 | 388661000 | 3671000000 |
| Friday, January 1, 2021 | 396028000 | 3528000000 |
| Saturday, January 1, 2022 | 369090000 | 3445000000 |
| Sunday, January 1, 2023 | 402466000 | 3498000000 |
| Monday, January 1, 2024 | 3702000000 |
Cracking the code
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Over the past decade, Teva Pharmaceutical Industries Limited and ACADIA Pharmaceuticals Inc. have showcased contrasting strategies in this domain. From 2014 to 2023, Teva's SG&A expenses have seen a significant decline of approximately 31%, dropping from $5.08 billion to $3.50 billion. This reduction reflects Teva's strategic cost-cutting measures amidst challenging market conditions. In contrast, ACADIA's SG&A expenses have surged by over 1,100%, from $32.7 million to $402.5 million, indicating aggressive investment in growth and expansion. While Teva focuses on efficiency, ACADIA's approach highlights its commitment to scaling operations. This divergence in strategies offers a fascinating insight into how two industry players navigate financial management to achieve their corporate goals.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Teva Pharmaceutical Industries Limited
Breaking Down SG&A Expenses: argenx SE vs Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Supernus Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends